A detailed history of Arizona State Retirement System transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 13,372 shares of RCUS stock, worth $188,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,372
Previous 13,538 1.23%
Holding current value
$188,812
Previous $258,000 2.33%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$14.83 - $20.18 $2,461 - $3,349
-166 Reduced 1.23%
13,372 $252,000
Q4 2023

Jan 24, 2024

BUY
$13.43 - $19.63 $107 - $157
8 Added 0.06%
13,538 $258,000
Q3 2023

Nov 06, 2023

BUY
$17.62 - $23.54 $21,602 - $28,860
1,226 Added 9.96%
13,530 $242,000
Q2 2023

Aug 01, 2023

SELL
$16.97 - $22.03 $4,819 - $6,256
-284 Reduced 2.26%
12,304 $249,000
Q1 2023

Apr 27, 2023

BUY
$15.96 - $23.15 $5,921 - $8,588
371 Added 3.04%
12,588 $229,000
Q4 2022

Feb 07, 2023

BUY
$19.7 - $35.71 $10,303 - $18,676
523 Added 4.47%
12,217 $252,000
Q3 2022

Nov 07, 2022

BUY
$23.23 - $30.07 $3,228 - $4,179
139 Added 1.2%
11,694 $306,000
Q2 2022

Jul 28, 2022

BUY
$17.23 - $37.73 $19,142 - $41,918
1,111 Added 10.64%
11,555 $293,000
Q1 2022

May 04, 2022

SELL
$28.92 - $41.83 $3,615 - $5,228
-125 Reduced 1.18%
10,444 $330,000
Q4 2021

Feb 04, 2022

SELL
$31.38 - $48.47 $2,102 - $3,247
-67 Reduced 0.63%
10,569 $428,000
Q3 2021

Nov 12, 2021

BUY
$26.93 - $37.68 $1,077 - $1,507
40 Added 0.38%
10,636 $371,000
Q2 2021

Aug 02, 2021

SELL
$22.75 - $35.77 $38,424 - $60,415
-1,689 Reduced 13.75%
10,596 $291,000
Q1 2021

May 06, 2021

BUY
$26.16 - $41.39 $1,308 - $2,069
50 Added 0.41%
12,285 $345,000
Q4 2020

Jan 28, 2021

BUY
$17.0 - $32.36 $18,428 - $35,078
1,084 Added 9.72%
12,235 $318,000
Q3 2020

Nov 05, 2020

BUY
$17.14 - $25.47 $48,231 - $71,672
2,814 Added 33.75%
11,151 $191,000
Q2 2020

Aug 04, 2020

BUY
$13.97 - $36.56 $116,467 - $304,800
8,337 New
8,337 $206,000

Others Institutions Holding RCUS

About Arcus Biosciences, Inc.


  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $1.02B
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.